Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas

ConclusionNMBR antagonist represents a potential treatment for CD and its effect may be mediated by cyclin E suppression.
Source: Pituitary - Category: Endocrinology Source Type: research